about
FAM83A confers EGFR-TKI resistance in breast cancer cells and in miceIL-25 causes apoptosis of IL-25R-expressing breast cancer cells without toxicity to nonmalignant cellsIdentification of a novel putative non-selenocysteine containing phospholipid hydroperoxide glutathione peroxidase (NPGPx) essential for alleviating oxidative stress generated from polyunsaturated fatty acids in breast cancer cells.ATM suppresses SATB1-induced malignant progression in breast epithelial cellsNFkB disrupts tissue polarity in 3D by preventing integration of microenvironmental signals.Pathways Involved in Formation of Mammary Organoid Architecture Have Keys to Understanding Drug Resistance and to Discovery of Druggable Targets.Removal of BRCA1/CtIP/ZBRK1 repressor complex on ANG1 promoter leads to accelerated mammary tumor growth contributed by prominent vasculature.Copper uptake is required for pyrrolidine dithiocarbamate-mediated oxidation and protein level increase of p53 in cells.Development of a sensitive assay to detect reversibly oxidized protein cysteine sulfhydryl groups.Brca1 heterozygous mice have shortened life span and are prone to ovarian tumorigenesis with haploinsufficiency upon ionizing irradiation.Basal S-Nitrosylation Is the Guardian of Tissue Homeostasis.Laminin signals initiate the reciprocal loop that informs breast-specific gene expression and homeostasis by activating NO, p53 and microRNAs.Transient external force induces phenotypic reversion of malignant epithelial structures via nitric oxide signaling.Caveolin-1: would-be Achilles' heel of tumor microenvironment?Reduced Basal Nitric Oxide Production Induces Precancerous Mammary Lesions via ERBB2 and TGFβCorrection of arginine metabolism with sepiapterin-the precursor of nitric oxide synthase cofactor BH4-induces immunostimulatory-shift of breast cancerS-Nitrosylation: An Emerging Paradigm of Redox Signaling
P50
Q24296333-D63969B5-6CE3-4981-A565-9E0FF6C8B1E5Q24634798-67B9C154-C93A-419C-B171-4E12CBE5BA53Q34338767-62D61409-0F3C-45AA-AF33-028058F743CCQ34517226-EAFE4161-97D8-4970-BDD8-92CDC3A09D78Q37420178-52DD149C-99CE-44D6-B875-68CB672C33D0Q39247023-8DE1333F-8100-4F3D-8E84-4FB8B212B2F1Q40255561-0FB13D4C-3A3F-4756-B789-5BC7E5349B3EQ43002029-472E6D4B-39F8-426E-B87D-781E92D1648BQ43868228-4A3FBDC0-F810-44D5-9E4A-49724410AF25Q45937177-88E822C9-0151-4FFA-9CC3-5A3A5049A8A4Q47421560-533C0E68-A660-4AB0-817E-779E30CA49BDQ52725291-F21E9070-805A-440E-B8AB-34880F3E3509Q52725293-C769AA86-E188-4184-905A-B64F825A7E95Q53210155-D75E83AF-88DF-4317-A9F3-E3BB70DFF1CEQ64080512-114F80DC-4714-49DC-AD09-BBFA0773E581Q89952047-8D952726-37E8-4F83-A891-2B1EAB12582CQ90163923-EBDC74DD-64E3-4D8A-B48B-5FBF249FB3C6
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Saori Furuta
@ast
Saori Furuta
@en
Saori Furuta
@es
Saori Furuta
@nl
Saori Furuta
@sl
type
label
Saori Furuta
@ast
Saori Furuta
@en
Saori Furuta
@es
Saori Furuta
@nl
Saori Furuta
@sl
prefLabel
Saori Furuta
@ast
Saori Furuta
@en
Saori Furuta
@es
Saori Furuta
@nl
Saori Furuta
@sl
P106
P21
P31
P496
0000-0003-1121-0487